| Dr Sylvia Burson Rushing, MD | |
|
4300 W Main St, Suite 102, Dothan, AL 36305-1054 | |
| (334) 793-9564 | |
| (334) 671-8907 |
| Full Name | Dr Sylvia Burson Rushing |
|---|---|
| Gender | Female |
| Speciality | Interventional Cardiology |
| Experience | 41 Years |
| Location | 4300 W Main St, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578562484 | NPI | - | NPPES |
| 127015 | Medicaid | AL | |
| 060016521 | Other | LA | MEDICARE RAILROAD |
| 1378992 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 014534 (Louisiana) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 017394 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flowers Hospital | Dothan, AL | Hospital |
| Medical Center Enterprise | Enterprise, AL | Hospital |
| Medical Center Barbour | Eufaula, AL | Hospital |
| Northwest Florida Community Hospital | Chipley, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiology Associates, Pa | 1153361225 | 11 |
News Archive
Those who have emphysema may soon be able to breathe a sigh of relief. That's because alternative ways to treat advanced cases of the condition are being developed.
More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, following FDA 510(k) clearance in June and a limited pre-launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as announced in March 2008.
Strapped into a motion-enabled simulator and wearing 3D glasses, 36 adolescent volunteers recently experienced what it was like to "travel" through a field of virtual stars. The experiments provided new and convention-busting data about how sensory stimuli are processed by the brains of individuals with Autism Spectrum Disorder.
Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth.
› Verified 8 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Those who have emphysema may soon be able to breathe a sigh of relief. That's because alternative ways to treat advanced cases of the condition are being developed.
More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, following FDA 510(k) clearance in June and a limited pre-launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as announced in March 2008.
Strapped into a motion-enabled simulator and wearing 3D glasses, 36 adolescent volunteers recently experienced what it was like to "travel" through a field of virtual stars. The experiments provided new and convention-busting data about how sensory stimuli are processed by the brains of individuals with Autism Spectrum Disorder.
Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth.
› Verified 8 days ago
| Entity Name | Cardiology Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922088798 PECOS PAC ID: 1153361225 Enrollment ID: O20050509000204 |
News Archive
Those who have emphysema may soon be able to breathe a sigh of relief. That's because alternative ways to treat advanced cases of the condition are being developed.
More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, following FDA 510(k) clearance in June and a limited pre-launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as announced in March 2008.
Strapped into a motion-enabled simulator and wearing 3D glasses, 36 adolescent volunteers recently experienced what it was like to "travel" through a field of virtual stars. The experiments provided new and convention-busting data about how sensory stimuli are processed by the brains of individuals with Autism Spectrum Disorder.
Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sylvia Burson Rushing, MD 4300 W Main St, Suite 102, Dothan, AL 36305-1054 Ph: (334) 793-9564 | Dr Sylvia Burson Rushing, MD 4300 W Main St, Suite 102, Dothan, AL 36305-1054 Ph: (334) 793-9564 |
News Archive
Those who have emphysema may soon be able to breathe a sigh of relief. That's because alternative ways to treat advanced cases of the condition are being developed.
More patients with ovarian carcinoma carry cancer-predisposing mutations, and in more genes, than previously thought.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, following FDA 510(k) clearance in June and a limited pre-launch in July. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as announced in March 2008.
Strapped into a motion-enabled simulator and wearing 3D glasses, 36 adolescent volunteers recently experienced what it was like to "travel" through a field of virtual stars. The experiments provided new and convention-busting data about how sensory stimuli are processed by the brains of individuals with Autism Spectrum Disorder.
Saint Louis University researchers are studying how fetal exposure to inflammation can alter immune responses after birth.
› Verified 8 days ago
Parks Winfield Pratt Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St, Suite 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-671-8907 | |
Mr. Rodney K Beauchamp, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Parkwest Cir Ste 2, Dothan, AL 36303 Phone: 334-699-2004 | |
Brian Reynolds Sinclair, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Ross Clark Cir Ste 400, Dothan, AL 36301 Phone: 334-305-0400 Fax: 334-305-0401 | |
Dr. Olawale Mayokun Osunsanya, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1763 E Main St, Dothan, AL 36301 Phone: 334-793-3319 Fax: 334-793-2291 | |
Jeffrey John Crittenden, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 480 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-1212 Fax: 334-836-1888 | |
Dr. Venkat R Nimmagadda, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1540 E Main St, Dothan, AL 36301 Phone: 334-793-2618 Fax: 334-792-7353 | |
Christopher O. Ike, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-340-2805 |